PPARα agonist Wy14643 enhances wakefulness as well as contents of catecholamines and adenosine.
PPARα antagonist MK-886 increases sleep and decreases the levels of catecholamines as well as adenosine.
PPARα modulates sleep–wake cycle and neurochemicals.